What does NATESSENCE do?

NATESSENCE is a pharmacy in Ecaussinnes. Public Limited, started on 29 March 1993, 1 establishment.

What is the address of NATESSENCE?

The registered office of NATESSENCE is located at Rue de l'Avedelle 164, 7190 Ecaussinnes.

Is NATESSENCE still active?

Yes. According to the CBE (30 October 2026) NATESSENCE is active, legal situation “Normale toestand”, started on 29 March 1993.

Is NATESSENCE registered on Peppol?

Yes, NATESSENCE is registered on the Peppol network with ID 0208:0449788802.

What is the enterprise number of NATESSENCE?

The enterprise number of NATESSENCE is BE0449788802.

When was NATESSENCE founded?

NATESSENCE was founded on 29 March 1993.

Who are the directors of NATESSENCE?

According to the 2025 annual accounts, the directors of NATESSENCE are: CASSART PHARMA SRL SRL.

Is NATESSENCE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 March 1993; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did NATESSENCE make in 2025?

NATESSENCE recorded a loss after taxes of € 9,786 in financial year 2025.

What is the revenue of NATESSENCE?

As a small company, NATESSENCE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 164,345.

How much does an employee at NATESSENCE earn?

The average wage cost per full-time employee at NATESSENCE was € 66,800 in 2023: staff costs of € 120,160 for 1.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does NATESSENCE have?

According to the 2025 annual accounts, NATESSENCE has 0.9 full-time equivalents (FTE).

NATESSENCE (Public Limited) - Ecaussinnes - BE0449788802

Dossier NATESSENCE, printed on 30 October 2026 from databakkes.be/en/0449788802/natessence. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

NATESSENCE from Ecaussinnes, company number BE0449788802, closed financial year 2025 with a result of € -9,786 after tax. For that financial year NATESSENCE recorded a gross margin of € 164,345 and equity of € 648,730. Compared with financial year 2024, the result moved from € 18,761 to € -9,786. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Healthy

€ 648,730

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -9,786

▼ still € 18,761 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 182,776

▲ 54% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 586,730.

People and assets in 2025

Full-time equivalents

0.9

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 43,435

▲ 17% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,925

▲ 85% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 17 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 551,053

▼ 5% vs 2024

€ 32,630 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.

Owed to suppliers

€ 191,687

▲ 56% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,728

▼ 32% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 386,439 Gross margin 2022: € 386,439 First fiscal year in the series	€ 300,640 Gross margin 2023: € 300,640 ▼ 22% vs 2022 (€ 386,439) Unfavourable step	€ 171,963 Gross margin 2024: € 171,963 ▼ 43% vs 2023 (€ 300,640) Unfavourable step	€ 164,345 Gross margin 2025: € 164,345 ▼ 4% vs 2024 (€ 171,963) Unfavourable step	▼ 4%
Profit after taxes	€ 73,240 Profit after taxes 2022: € 73,240 First fiscal year in the series	€ 49,959 Profit after taxes 2023: € 49,959 ▼ 32% vs 2022 (€ 73,240) Unfavourable step	€ 18,761 Profit after taxes 2024: € 18,761 ▼ 62% vs 2023 (€ 49,959) Unfavourable step	€ -9,786 Profit after taxes 2025: € -9,786 ▼ € 28,548 vs 2024 (€ 18,761) Unfavourable step	▼ € 28,548
Equity	€ 779,796 Equity 2022: € 779,796 First fiscal year in the series	€ 829,755 Equity 2023: € 829,755 ▲ 6% vs 2022 (€ 779,796) Favourable step	€ 658,516 Equity 2024: € 658,516 ▼ 21% vs 2023 (€ 829,755) Unfavourable step	€ 648,730 Equity 2025: € 648,730 ▼ 1% vs 2024 (€ 658,516) Unfavourable step	▼ 1%
Total debts	€ 904,448 Total debts 2022: € 904,448 First fiscal year in the series	€ 826,397 Total debts 2023: € 826,397 ▼ 9% vs 2022 (€ 904,448) Favourable step	€ 716,948 Total debts 2024: € 716,948 ▼ 13% vs 2023 (€ 826,397) Favourable step	€ 752,105 Total debts 2025: € 752,105 ▲ 5% vs 2024 (€ 716,948) Unfavourable step	▲ 5%
Cash	€ 438,551 Cash 2022: € 438,551 First fiscal year in the series	€ 316,473 Cash 2023: € 316,473 ▼ 28% vs 2022 (€ 438,551) Unfavourable step	€ 118,408 Cash 2024: € 118,408 ▼ 63% vs 2023 (€ 316,473) Unfavourable step	€ 182,776 Cash 2025: € 182,776 ▲ 54% vs 2024 (€ 118,408) Favourable step	▲ 54%
Land & buildings	€ 1,067,291 Land & buildings 2022: € 1,067,291 First fiscal year in the series	€ 976,100 Land & buildings 2023: € 976,100 ▼ 9% vs 2022 (€ 1,067,291) Unchanged	€ 884,909 Land & buildings 2024: € 884,909 ▼ 9% vs 2023 (€ 976,100) Unchanged	€ 797,173 Land & buildings 2025: € 797,173 ▼ 10% vs 2024 (€ 884,909) Unchanged	▼ 10%
Retained profit	€ 717,796 Retained profit 2022: € 717,796 First fiscal year in the series	€ 767,755 Retained profit 2023: € 767,755 ▲ 7% vs 2022 (€ 717,796) Favourable step	€ 596,516 Retained profit 2024: € 596,516 ▼ 22% vs 2023 (€ 767,755) Unfavourable step	€ 586,730 Retained profit 2025: € 586,730 ▼ 2% vs 2024 (€ 596,516) Unfavourable step	▼ 2%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 190,000 Dividend 2024: € 190,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 190,000) Unchanged	▼ 100%
Bank debt	€ 753,553 Bank debt 2022: € 753,553 First fiscal year in the series	€ 608,254 Bank debt 2023: € 608,254 ▼ 19% vs 2022 (€ 753,553) Favourable step	€ 582,391 Bank debt 2024: € 582,391 ▼ 4% vs 2023 (€ 608,254) Favourable step	€ 551,053 Bank debt 2025: € 551,053 ▼ 5% vs 2024 (€ 582,391) Favourable step	▼ 5%
Balance sheet total	€ 1,724,689 Balance sheet total 2022: € 1,724,689 First fiscal year in the series	€ 1,693,708 Balance sheet total 2023: € 1,693,708 ▼ 2% vs 2022 (€ 1,724,689) Unchanged	€ 1,410,131 Balance sheet total 2024: € 1,410,131 ▼ 17% vs 2023 (€ 1,693,708) Unchanged	€ 1,432,613 Balance sheet total 2025: € 1,432,613 ▲ 2% vs 2024 (€ 1,410,131) Unchanged	▲ 2%
Employees (FTE)	1.8 Employees (FTE) 2022: 1.8 First fiscal year in the series	1.8 Employees (FTE) 2023: 1.8 Unchanged (1.8) Unchanged	0.8 Employees (FTE) 2024: 0.8 ▼ 1 vs 2023 (1.8) Unchanged	0.9 Employees (FTE) 2025: 0.9 ▲ 0.1 vs 2024 (0.8) Unchanged	▲ 0.1

Key figures of NATESSENCE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NATESSENCE?

What happened at NATESSENCE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: loss of € 9,786 (▼ € 28,548 vs 2024). Source: NBB ↗
Jun 8, 1993 New establishment in Ecaussinnes. KBO
Mar 29, 1993 Start of the company according to the CBE. KBO

In short

From € 73,240 profit in 2022 to € 9,786 loss in 2025.

Paid € 64,249 in corporate taxes since 2022.

Best year ever: 2022, with € 73,240 profit.

On average € 167,000 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

CASSART PHARMA 100%

The stake of CASSART PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

NATESSENCE

Behind NATESSENCE is CASSART PHARMA SRL SRL. The shares are held by CASSART PHARMA (100%).

Directors

According to the 2025 annual accounts

CASSART PHARMA SRL SRL

Director · represented by Cassart François Pierre

Shareholders

CASSART PHARMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de l'Avedelle 164

7190 Ecaussinnes

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

GROUPE NATESSENCE

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0449.788.802

VAT number

BE 0449.788.802

Registered office

Rue de l'Avedelle 164, 7190 Ecaussinnes

Names & denominations

NATESSENCE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

29 March 1993

Peppol

Active · Active since 12 Sept 2025

Contact

[email protected]

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

NATESSENCE

Financials

What happened to NATESSENCE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions